MSI-L
About
Biomarker type: Microsatellite stability
Status: Microsatellite instability-low (MSI-L)
Mappings
Therapeutic response
Precision oncology relationships for therapeutic response involving this biomarker.
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (1) | MSI-L | Endometrial Carcinoma | Lenvatinib, Pembrolizumab |